-
NACI to recommend AZ vaccine for Canadians over age 65 based on positive real-world results after millions of doses. It has a comparable reduction in the risk of symptomatic disease and hospitalization compared to 18-64 year-olds.
Medical Mythbusting Commentary for March 16, 2021 Source:Canada will recommend AstraZeneca-Oxford vaccine for those over 65, documents show
-
Does Oxford-AstraZeneca vaccine increase risk of blood clots? To conclude this would require evidence that incidence exceeds what is normally expected in the general population. To date, this is not the case according to reports from health authorities.
Medical Mythbusting Commentary for March 12, 2021 Source:No sign Oxford-AstraZeneca vaccine causes blood clots: Canadian health authorities
-
Vaccine choice? They all work. They all prevent what matters most: severe disease and hospitalization. No need to wait for one over the other.
Sunday House Call, #779, February 28, 2021 There are reports about what coronavirus vaccine someone should get. There is a good review of all the vaccines are available. In short, they all work extremely well and are all close to if not at 100% prevention of severe disease and hospitalization. There is no reason to…
-
Lancet posts Oxford Vaccine Group preprint study on how the timing of the booster dose of its Oxford-AZ vaccine affects the immune response and efficacy for people 18-55 years of age.
Medical Mythbusting Commentary for February 4, 2021 Source:U.K. says new study vindicates delaying 2nd AstraZeneca shot Reference:Single Dose Administration, And The Influence Of The Timing Of The Booster Dose On Immunogenicity and Efficacy Of ChAdOx1 nCoV-19 (AZD1222) Vaccine